PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The BMJ investigates concerns over informed consent for pregnant women in Pfizer’s RSV vaccine trial

Should mums-to-be have been told of safety signal around preterm birth?

2023-11-16
(Press-News.org) A debate has broken out over whether Pfizer should have told pregnant women taking part in its maternal respiratory syncytial virus (RSV) vaccine trial that a trial of a similar GSK vaccine was stopped over a safety signal around preterm birth, an investigation by The BMJ can reveal.

Pfizer’s vaccine, called Abrysvo, was recently approved for use in the US and the European Union, but is not yet authorised in the UK.

Some experts have criticised Pfizer for not informing participants, while others believe notification would have been premature and caused unnecessary anxiety, reports freelance investigative journalist Hristio Boytchev.

RSV is a common respiratory virus that usually causes mild, cold-like symptoms but it can be severe, especially in young children, and is a significant cause of infant death globally.

Both GSK and Pfizer were developing recombinant RSV F protein vaccines to inoculate pregnant women and protect their babies. 

In February 2022, GSK halted its phase 3 trial after a possible increased risk of preterm births emerged. GSK is still investigating the cause, which experts think may be unrelated to the vaccine, but it is no longer developing its vaccine.

Pfizer was also studying preterm births as an adverse event of special interest in its own phase 3 trial and a numerical (not statistically significant) imbalance in preterm births has recently emerged, though there is not enough data to understand if there is truly an increased risk or what the cause is.

After GSK’s trial was halted, there was a split opinion between clinical trial ethicists and some vaccine researchers over whether Pfizer should have informed all participating women in its trial about the potential risk or updated its consent forms. 

Charles Weijer, bioethics professor at Western University in London, Canada told The BMJ that informing pregnant women in Pfizer’s trial about GSK’s results would have allowed women who had not yet received the jab to consider whether they still wished to get it, and the ones who had already received it to seek additional medical advice and follow-up. “Any failure to provide new and potentially important safety information data to trial participants is ethically problematic”, Weijer said.  

Pfizer has also been criticised for a passage in some of its trial consent forms, seen by The BMJ, which said that its vaccine candidate was risk-free for the baby, assurances a research ethics expert described as “misleading” and “irresponsible”.

Pfizer did not respond to The BMJ’s questions on the issue of informed consent.

Regulators have taken different approaches when approving Abrysvo, notes Boytchev. For example, the US Food and Drug Administration (FDA) approved it with conditions, including only administering to women who are 32-36 weeks pregnant and a warning in the prescribing information of a numerical imbalance in preterm births. The FDA is requiring Pfizer to conduct postmarketing studies to “assess the signal of serious risk of preterm birth.” 

Yet others such as the European Medicines Agency (EMA) and the UK’s Joint Committee on Vaccination and Immunisation (JCVI), did not consider a warning around the possible risk of preterm birth or restricting the use of the vaccine to the later weeks of pregnancy necessary.

As Pfizer didn’t respond to the questions about whether it had informed expectant mothers in its trial about GSK’s results, The BMJ contacted governmental health authorities in all 18 countries where Pfizer had trial sites, as well as more than 80 trial investigators, and none answered saying that it had. 

Some confirmed that Pfizer continued to enrol and vaccinate women for months after the news of the potential risk of preterm birth in GSK’s vaccine trial was made public.

One trial investigator, speaking anonymously because they had signed a confidentiality agreement with the company, said they questioned Pfizer early in 2022 about the potential risk of preterm birth given the similarity between Pfizer and GSK’s products, but was told their data hadn't shown any increase in risk.

Other trial investigators disagreed with the notion that participants should have been informed. Beate Kampmann, director of the Centre for Global Health at Charite University Hospital Berlin, one of the lead authors of Pfizer’s phase 3 trial paper, and who was responsible for a trial site in the Gambia, said that GSK’s results weren’t relevant to her trial participants “as most participants were already in follow up.”

Some Pfizer trial consent forms seen by The BMJ contain contradictory statements, both warning of possible “life-threatening” effects of the vaccine on the baby while simultaneously carrying a passage that said only the expectant mother is at risk from adverse effects.

“Knowing what we know now, the statement in question is irresponsible and, given the benefit of hindsight, is actually factually incorrect,” said Rose Bernabe, professor of research ethics and research integrity at the University of Oslo. “Considering the gravity of the risk that this irresponsible statement veils, this misleading statement should be a ground for questioning the validity of the consent process.”

END


ELSE PRESS RELEASES FROM THIS DATE:

No one-size-fits-all solution for the net-zero grid, Surrey research demonstrates

2023-11-16
As power generation from sources like solar and wind increases, along with the introduction of devices such as heat pumps and batteries, a new optimisation tool created at the University of Surrey will help the UK plan for a greener electricity network.   The researchers developed an algorithm to model how these smaller networks distributed electricity – factoring in how local grids could become unbalanced by adding too many heat pumps in a single area or generating more electricity than the grid could accept.   The Surrey team found that it was generally more efficient ...

Nuclear expansion failure shows simulations require change

2023-11-16
The widespread adoption of nuclear power was predicted by computer simulations more than four decades ago but the continued reliance on fossil fuels for energy shows these simulations need improvement, a new study has shown.  In order to assess the efficacy of energy policies implemented today, a team of researchers looked back at the influential 1980s model that predicted nuclear power would expand dramatically. Energy policies shapes how we produce and use energy, impacting jobs, costs, climate, and security. These policies are generated using simulations (also ...

7 countries, 1.3 million lives lost – the devastating impact of tobacco revealed

2023-11-16
Strict embargo: 00.01 hrs GMT Thursday, 16th September, 2023    Every year 1.3 million lives are lost to cancers caused by smoking tobacco across the UK, US and BRICS nations (Brazil, Russia, India, China and South Africa), according to a new study, funded by Cancer Research UK.  Researchers found that together, the seven countries represented more than half of the global burden of cancer deaths every year. They concluded that smoking, as well as three other preventable risk factors – alcohol, overweight or obesity, and human papillomavirus (HPV) infections caused almost 2 million deaths combined.  The study, carried out ...

Pancreatic cancer discovery opens the door for new clinical trial

Pancreatic cancer discovery opens the door for new clinical trial
2023-11-16
Pancreatic cancer is tricky to manage because it spreads easily and early, and the tumors have a unique biological makeup. But, researchers made a breakthrough by learning about the genetic changes that occur during tumor migration — and also found a drug that can obstruct the process. The next step is a groundbreaking clinical trial at the University of Rochester’s Wilmot Cancer Institute, planned for early in 2024, to test the drug from their laboratory discovery, said senior investigator Darren Carpizo, MD, PhD, co-leader of Wilmot’s Genetics, Epigenetics and Metabolism research program, and chief of Surgical Oncology at the University of Rochester Medical ...

UH researchers suggest hydrogen fuel can be a competitive alternative to gasoline and diesel today

2023-11-15
As the world strives to cut greenhouse gas emissions and find sustainable transportation solutions, University of Houston energy researchers suggest that hydrogen fuel can potentially be a cost-competitive and environmentally friendly alternative to traditional liquid fuels, and that supplying hydrogen for transportation in the greater Houston area can be profitable today. A white paper titled "Competitive Pricing of Hydrogen as an Economic Alternative to Gasoline and Diesel for the Houston Transportation Sector" examines the promise for the potential of hydrogen-powered fuel cell electric vehicles (FCEVs) ...

Climate change effects hit marine ecosystems in multiple waves, according to marine ecologists

Climate change effects hit marine ecosystems in multiple waves, according to marine ecologists
2023-11-15
PROVIDENCE, R.I. [Brown University] — A new approach to examining the effects of climate change on marine ecosystems may provide a more accurate understanding of climate change responses — and predictions for future consequences — according to a new paper co-authored by a Brown University biologist. The paper, published in the Annual Review of Ecology, Evolution, and Systematics, highlights the interplay between the trend of climate warming and the fluctuations in local temperature. These two properties cause atypically warm events such as marine heatwaves to occur with ...

Transplant researchers develop vaccine in preclinical models to regulate immune responses to prevent kidney and heart transplant rejection

2023-11-15
A subtype of CD8 T cells, which are classically known to promote immune system responses, may be in fact regulating the immune system by suppressing immune cells causing self-destructive responses leading to autoimmune disorders and organ graft rejection. A team led by researchers from the Department of Medicine and the Transplant Research Center at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, in collaboration with researchers from the Dana-Farber ...

More than meows: How bacteria help cats communicate

2023-11-15
any mammals, from domestic cats and dogs to giant pandas, use scent to communicate with each other. A new study from the University of California, Davis shows how domestic cats send signals to each other using odors derived from families of bacteria living in their anal glands. The work was published Nov. 8 in Scientific Reports. The study adds to a growing body of research on the relationship between microbes and odor in mammals, including domestic dogs, wild animals such as foxes, pandas and hyenas, and humans. Cats’ scent comes ...

Genetics study shines light on health disparities for IBD

Genetics study shines light on health disparities for IBD
2023-11-15
The advent of whole genome sequencing technology has prompted an explosion in research into how genetics are associated with disease risk. But the vast majority of genetics research has been done on people of European ancestry, and genetics researchers have realized that in order to address health disparities, more needs to be done. In a new study, Georgia Tech researchers investigated whether 25 rare gene variants known to be associated with inflammatory bowel disease (IBD) play a role in risk for African Americans. While the rare variant associations were recently discovered in individuals of European ancestry, ...

Physician burnout reduced with peer support, study finds

2023-11-15
A new Kaiser Permanente physician peer support program designed to reduce burnout helped improve doctors’ well-being and had a positive impact on the culture of the medical departments that took part in the program, Kaiser Permanente researchers found.   The study, published November 1 in PLOS ONE, analyzed the impact of the Kaiser Permanente Northern California (KPNC) Peer Outreach Support Team (POST) program in 2 KPNC hospitals. POST is now active in 10 KPNC hospitals, and 3 more hospitals intend to launch POST programs over the next few months. Uniquely, the POST program allows for third-party referrals — ...

LAST 30 PRESS RELEASES:

UC Irvine receives $15 million NSF grant for integrative movement research

University of Houston engineer Metin Akay featured in study highlighting 50 scientists' contributions to biomedical engineering advancements

JWST captures the end of planet formation

Good news—MS drugs taken while breastfeeding may not affect child development

Programs intended to reduce health insurance premiums may make coverage less affordable for the middle class

PrEP discontinuation in a US national cohort of sexual and gender minority populations, 2017–22

USC Study: Medicare Part D plans increased restrictions on drug coverage

Sacituzumab govitecan plus platinum-based chemotherapy in breast, bladder, and lung carcinomas

Global study unveils "problematic" use of porn

Newly discovered protein prevents DNA triplication

Less ice in the arctic ocean has complex effects on marine ecosystems and ocean productivity

Antarctica’s coasts are becoming less icy

New research shows migrating animals learn by experience

Modeling the origins of life: New evidence for an “RNA World”

Scientists put forth a smarter way to protect a smarter grid

An evolutionary mystery 125 million years in the making

Data science approach to identifying thermal conductivity-related structural factors in amorphous materials

Deciphering the male breast cancer genome

Detection of suicide-related emergencies among children using real-world clinical data: A free webinar from the Brain & Behavior Research Foundation

Editor-in-Chief of Sustainability and Climate Change Madhavi Venkatesan named USA TODAY Woman of the Year for Massachusetts for leading plastic bottle ban efforts

Tests show high-temperature superconducting magnets are ready for fusion

Zika vaccine safe, effective when administered during pregnancy

Firearm ownership is correlated with elevated lead levels in children, study finds

Role of African women and young people in agricultural service provision investigated in new CABI-led study

26th International Conference of the Redox Medicine Society Set for June 2024 in Paris, France

Geologists explore the hidden history of Colorado’s Spanish Peaks

Webb unlocks secrets of one of the most distant galaxies ever seen

3D-printed skin closes wounds and contains hair follicle precursors

Discovered a RNA molecule that helps prevent DNA replication errors

Small and overlooked: Amount of repetitive DNA in blood hints at cancer early

[Press-News.org] The BMJ investigates concerns over informed consent for pregnant women in Pfizer’s RSV vaccine trial
Should mums-to-be have been told of safety signal around preterm birth?